We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Anti‐Citrullinated Antibodies Associated with NET Formation in Rheumatoid Arthritis

By LabMedica International staff writers
Posted on 14 Dec 2020
Several cell types can form extracellular traps as a primary immune response when pathogens invade the body or other inflammatory stimuli. These cell types include neutrophils, monocytes, eosinophils, and mast cells. The mechanism by which neutrophil extracellular traps (NETs) are formed is known as NETosis.

Rheumatoid arthritis (RA) is a chronic autoimmune disease mainly involving inflammation of the cartilage and joints. A broad spectrum of autoantibodies is found in sera collected from patients with RA. However, anti‐citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are the two autoantibodies most often used for the diagnosis and prognosis prediction of RA.

Image: Rheumatoid arthritis (RA)‐derived neutrophils exhibited increased spontaneous NETosis and increased NETotic response to tumor necrosis factor (TNF)‐α. Neutrophils were isolated from patients with RA and healthy controls (HC) (Photo courtesy of Central South University).
Image: Rheumatoid arthritis (RA)‐derived neutrophils exhibited increased spontaneous NETosis and increased NETotic response to tumor necrosis factor (TNF)‐α. Neutrophils were isolated from patients with RA and healthy controls (HC) (Photo courtesy of Central South University).

Clinical Scientists at the Central South University (Changsha, China) collected peripheral blood (PB), serum, and synovial tissue were obtained from patients with RA. Several parameters associated with RA severity, namely 28‐joint disease activity score (DAS28), erythrocyte sedimentation rate (ESR), and serum C‐reactive protein (CRP) and ACPA were measured during a clinical visit. ESR was measured by the Westergren method. ACPA was detected using an Immunoscan CCPlus commercial enzyme‐linked immunosorbent assay (ELISA) kit (Euro‐Diagnostica; Malmö, Sweden).

Serum NET remnants were detected by an ELISA in 51 patients with RA and 40 age‐ and sex‐matched healthy controls. MPO‐DNA complexes and NE‐DNA complexes were evaluated. Neutrophils were isolated by density gradient centrifugation using Polymorphprep solution (Axis‐Shield, Dundee, UK). Neutrophil extracellular traps were detected using an immunofluorescent method. Fibroblast‐like synoviocyte cells (FLS) were collected to determine the mRNA expression levels of IL‐6 and IL‐8 by real‐time polymerase chain reaction (PCR).

The team reported that in RA patients, NET remnants in the peripheral circulation were higher in extremely high ACPA titers when compared to in moderate ACPA titers. IgG antibodies containing ACPA can stimulate neutrophils to form NETs in a concentration‐dependent manner. Furthermore, significantly higher expression of the pro‐inflammatory cytokines IL‐6 and IL‐8 is detected after FLS cells interacted with NETs which derived from neutrophils stimulated with ACPA‐containing IgG antibodies.

The authors concluded that anti‐citrullinated protein antibodies may enhance NET formation and contribute to inflammation development in RA by stimulating NET formation, such as by subsequent activation of FLS cells by NETs. The study was published on November 28, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Central South University
Euro‐Diagnostica
Axis‐Shield



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Myocardial Infarction Test
Finecare cTn I/NT-proBNP Rapid Quantitative Test
New
Mini Vortex Mixer
Vornado

Latest Immunology News

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

Treatment Switching Guided by Liquid Biopsy Blood Tests Improves Outcomes for Breast Cancer Patients

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop